STOK
Stoke Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$27.68-4.72%
Price as of Jul 20, 2026
STOK valuation
Stoke Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 45.97x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.37x
- Price / sales
- 53.74x
- Price / cash flow
- -11.74x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 43.14x
- EV / EBITDA
- -8.43x
- EV / EBIT
- -7.47x
- Market cap
- $1.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.